Efficacy and safety of molnupiravir for COVID-19 patients.

Fatima, Maurish; Azeem, Saleha; Saeed, Junaid; Shahid, Abia; Cheema, Huzaifa Ahmad

Fatima, Maurish; Azeem, Saleha; Saeed, Junaid; Shahid, Abia; Cheema, Huzaifa Ahmad.

Fatima M; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Azeem S; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Saeed J; Department of Medicine, Nishtar Medical University, Lahore, Pakistan.
Shahid A; Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Cheema HA; Department of Medicine, King Edward Medical University, Lahore, Pakistan. Electronic address: huzaifacheema@kemu.edu.pk.

Eur J Intern Med ; 102: 118-121, 2022 08.

Article in English | MEDLINE | ID: covidwho-1867108

Subject(s)

COVID-19; Antiviral Agents/adverse effects; Cytidine/analogs & derivatives; Humans; Hydroxylamines

Keywords

COVID-19; EIDD-2801; MK-4482; Meta-analysis; Molnupiravir; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: J.ejim.2022.05.024

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google